chr10-71800739-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 0P and 0B.
The NM_022124.6(CDH23):c.7466G>A(p.Arg2489His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000403 in 1,613,878 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. R2489R) has been classified as Benign.
Frequency
Consequence
NM_022124.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDH23 | NM_022124.6 | c.7466G>A | p.Arg2489His | missense_variant | 53/70 | ENST00000224721.12 | NP_071407.4 | |
CDH23 | NM_001171933.1 | c.746G>A | p.Arg249His | missense_variant | 6/23 | NP_001165404.1 | ||
CDH23 | NM_001171934.1 | c.746G>A | p.Arg249His | missense_variant | 6/22 | NP_001165405.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDH23 | ENST00000224721.12 | c.7466G>A | p.Arg2489His | missense_variant | 53/70 | 5 | NM_022124.6 | ENSP00000224721.9 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152134Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000241 AC: 6AN: 249054Hom.: 0 AF XY: 0.0000296 AC XY: 4AN XY: 135122
GnomAD4 exome AF: 0.0000411 AC: 60AN: 1461626Hom.: 0 Cov.: 30 AF XY: 0.0000413 AC XY: 30AN XY: 727088
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152252Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74454
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Oct 14, 2019 | Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Identified in unrelated individuals with hearing loss and/or clinical diagnosis of Usher syndrome in the heterozygous state as well as in the presence of a second CDH23 variant in published literature (Wagatsuma et al., 2007; Mizutari et al., 2015; Zhao et al., 2015); This variant is associated with the following publications: (PMID: 25472526, 17850630, 25963016) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 30, 2021 | This sequence change replaces arginine with histidine at codon 2489 of the CDH23 protein (p.Arg2489His). The arginine residue is highly conserved and there is a small physicochemical difference between arginine and histidine. This variant is present in population databases (rs141986620, ExAC 0.002%). This variant has been observed in individual(s) with CDH23-related conditions (PMID: 17850630, 25472526, 25963016). ClinVar contains an entry for this variant (Variation ID: 504515). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Not Available"; Align-GVGD: "Class C25"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Autosomal recessive nonsyndromic hearing loss 12;C1832845:Usher syndrome type 1D;C4539685:Pituitary adenoma 5, multiple types Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Mar 01, 2022 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 28, 2017 | The p.Arg2489His variant in CDH23 has been reported in 1 individual with atypica l Usher syndrome who also had a second pathogenic variant in CDH23 and a possibl e viral etiology (Zhao 2015). It has also been reported in the heterozygous stat e in 2 individuals with hearing loss (Wagatsuma 2007, Mizutari 2015). The p.Arg2 489His variant has been identified in 4/111634 European chromosomes by the Genom e Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs141986 620). Although this variant has been seen in the general population, its frequen cy is not high enough to rule out a pathogenic role. Computational prediction to ols and conservation analysis suggest that the p.Arg2489His variant may impact t he protein, though this information is not predictive enough to determine pathog enicity. In summary, the clinical significance of the p.Arg2489His variant is un certain. - |
Pituitary adenoma 5, multiple types Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Jun 20, 2023 | - - |
Usher syndrome type 1 Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Mar 25, 2020 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at